Literature DB >> 15912205

Pre-eclampsia-associated alterations in Wharton's jelly proteoglycans.

Tomasz Gogiel1, Zofia Galewska, Stefan Jaworski.   

Abstract

Proteoglycans of Wharton's jelly contain mainly chondroitin/dermatan sulphate chains. The predominant proteoglycan is decorin (core proteins of 45 and 47 kDa), although the core proteins of biglycan (45 kDa), versican (260 kDa) and of other proteoglycans (90, 110, 220 kDa) were also detected (Gogiel et al., 2003). The aim of the present study was to compare the proteoglycan composition of Wharton's jelly of newborns delivered by healthy mothers and those with pre-eclampsia. Proteoglycans from pre-eclamptic Wharton's jelly had a higher sulphated glycosaminoglycan/protein ratio than those of normal tissue. Pre-eclampsia is associated with a lower level of all proteoglycan core proteins, especially those of higher molecular mass (such as versican), although the same set of core proteins were found in normal and pre-eclamptic Wharton's jelly. The alterations in the proteoglycan composition of Wharton's jelly may affect the mechanical properties of the umbilical cord and, in the case of pre-eclampsia, disturb foetal blood circulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15912205

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  3 in total

1.  Determination of hyperelastic properties for umbilical artery in preeclampsia from uniaxial extension tests.

Authors:  R Blair Dodson; John T Martin; Kendall S Hunter; Virginia L Ferguson
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-03-31       Impact factor: 2.435

Review 2.  Extracellular matrix remodeling of the umbilical cord in pre-eclampsia as a risk factor for fetal hypertension.

Authors:  Lech Romanowicz; Zofia Galewska
Journal:  J Pregnancy       Date:  2010-12-29

3.  Biomarkers of Inflammation and Redox Imbalance in Umbilical Cord in Pregnancies with and without Preeclampsia and Consequent Perinatal Outcomes.

Authors:  Marilene Brandão Tenório Fragoso; Raphaela Costa Ferreira; Micaely Cristina Dos Santos Tenório; Fabiana Andréa Moura; Orlando Roberto Pimentel de Araújo; Nassib Bezerra Bueno; Marília Oliveira Fonseca Goulart; Alane Cabral Menezes de Oliveira
Journal:  Oxid Med Cell Longev       Date:  2021-11-09       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.